SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Drew Armstrong
Health
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
By
Drew Armstrong
and
Bloomberg
From Brussels to Sydney, cities around the world are lifting COVID-19 travel restrictions
By
Drew Armstrong
,
Demetrios Pogkas
, and others
Health
Biden plans to donate an additional 500 million Pfizer shots abroad
By
Josh Wingrove
,
Drew Armstrong
, and others
Health
CDC recruits outsiders to lead a new center on disease forecasting
By
Drew Armstrong
,
Fiona Rutherford
, and others
International
Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed
By
Riley Griffin
,
Drew Armstrong
, and others
Health
Trump names 2 new heads of ‘Operation Warp Speed,’ the effort to develop coronavirus vaccine
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Politics
The U.S. has a new plan to fast-track a COVID-19 vaccine: ‘Operation Warp Speed’
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Finance
Gilead shares tumble on reports that the Chinese trial of its coronavirus drug was not successful
By
Drew Armstrong
,
Robert Langreth
, and others
Health
Gilead stock surges on report of coronavirus drug patients ‘seeing rapid recoveries’
By
Drew Armstrong
and
Bloomberg
Health
The U.S. can’t contain coronavirus, it just hopes to mitigate its impact
By
Daniel Flatley
,
Drew Armstrong
, and others
Health
Coronavirus: Fewer than 6,000 samples have been tested in the U.S.
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Politics
Slashing Cigarette Nicotine Levels No Longer on FDA’s Agenda
By
Drew Armstrong
and
Bloomberg
MPW
Rite Aid Names New CEO, Brings Number of Women CEOs on Fortune 500 to Record High
By
Drew Armstrong
and
Bloomberg